Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Chickenpox × fludarabine phosphate × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Leukemia, Myeloid, Acute 51 Precursor Cell Lymphoblastic Leukemia-Lymphoma 38 Leukemia, Lymphocytic, Chronic, B-Cell 37 Myelodysplastic Syndromes 36 Leukemia 33 Lymphoma, Non-Hodgkin 29 Lymphoma 29 Multiple Myeloma 24 Lymphoma, Mantle-Cell 23 Lymphoma, Follicular 21 Hodgkin Disease 20 Melanoma 19 Lymphoma, Large B-Cell, Diffuse 18 Lymphoma, B-Cell, Marginal Zone 16 Burkitt Lymphoma 16 Leukemia, Myelomonocytic, Chronic 13 Recurrence 12 Hematologic Neoplasms 11 Anemia, Refractory, with Excess of Blasts 11 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10 Neoplasms, Plasma Cell 10 Myeloproliferative Disorders 10 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, B-Cell 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9 Congenital Abnormalities 9 Primary Myelofibrosis 8 Ovarian Neoplasms 8 Lymphoma, Large-Cell, Anaplastic 8 Leukemia, Myeloid, Chronic-Phase 7

Interventions

fludarabine phosphate 1 fludarabine 1 Herpes Zoster Vaccine 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01953900 2026-01-23

VEGAS

Baylor College of Medicine

Phase 1 Active not recruiting

Chickenpox, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡